05/15/2025 7:15 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2025 7:18 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
05/15/2025 7:21 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
05/15/2025 7:24 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
04/15/2025 7:35 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
04/15/2025 7:26 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2025 7:29 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
04/15/2025 7:32 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
03/31/2025 7:43 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
03/31/2025 7:40 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
03/31/2025 7:41 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for KZIA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kazia Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
03/31/2025 7:39 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2025 4:25 PM | Alumni Capital LP (Filed by) Kazia Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/13/2025 6:00 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2025 5:33 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
02/20/2025 3:53 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
02/20/2025 3:55 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
02/05/2025 11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
02/05/2025 3:39 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
02/03/2025 7:36 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 3:31 PM | Kazia Therapeutics (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
01/30/2025 6:57 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 7:02 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
01/30/2025 7:05 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
01/16/2025 9:40 AM | Alumni Capital LP (Filed by) Kazia Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/13/2025 7:00 AM | Kazia Therapeutics (Filer)
| Form 424B5 | |
01/13/2025 7:03 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025 7:05 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
01/13/2025 7:07 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
01/10/2025 7:00 AM | Kazia Therapeutics (Filer)
| Form 424B5 | |
12/31/2024 7:46 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/31/2024 7:49 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/31/2024 7:43 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024 8:01 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/11/2024 8:04 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/11/2024 7:58 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024 3:33 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/03/2024 3:38 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/02/2024 11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
12/02/2024 11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
11/27/2024 3:30 PM | Kazia Therapeutics (Filer)
| Form POS AM | |
White House to reset Social Security? (Ad) Elon Musk's parting DOGE gift looks set to shock America...
A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.  And it could have a major impact on how you collect Social Security - Click here to understand what' |
11/27/2024 3:30 PM | Kazia Therapeutics (Filer)
| Form POS AM | |
11/06/2024 6:53 PM | Kazia Therapeutics (Subject) PLATINUM INVESTMENT MANAGEMENT LTD (Filed by)
| Form SC 13G | |
11/01/2024 3:05 PM | Kazia Therapeutics (Filer)
| Form NT 20-F | |
10/24/2024 7:28 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/24/2024 7:33 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/24/2024 7:38 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/24/2024 7:22 AM | Kazia Therapeutics (Filer)
| Form 6-K/A | |
10/15/2024 6:01 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 6:03 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/15/2024 6:04 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/15/2024 6:06 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/02/2024 3:52 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/02/2024 3:55 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/02/2024 3:57 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/23/2024 8:27 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/23/2024 8:23 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 8:25 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/23/2024 8:26 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/13/2024 8:06 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024 8:10 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/13/2024 8:12 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/13/2024 8:14 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/12/2024 11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
09/04/2024 7:56 PM | Kazia Therapeutics (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
08/12/2024 6:28 PM | Alumni Capital LP (Filed by) Kazia Therapeutics (Subject)
| Form SC 13G/A | |
07/10/2024 8:26 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
07/10/2024 8:28 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
07/10/2024 8:28 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
07/10/2024 8:19 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/02/2024 4:29 PM | Alumni Capital LP (Filed by) Kazia Therapeutics (Subject)
| Form SC 13G | |
06/28/2024 3:27 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
06/24/2024 7:14 PM | Kazia Therapeutics (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
06/04/2024 11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
05/29/2024 7:55 AM | Kazia Therapeutics (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |